ApoB testing could steer cholesterol care toward fewer heart attacks and strokes
A Northwestern-led simulation study finds using apoB levels to guide cholesterol-lowering therapy may prevent more heart attacks and strokes over a lifetime and be cost-effective compared with LDL- or non-HDL-guided strategies, though apoB testing isn’t yet routine due to extra testing, cost, and current guideline adoption.